Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model

The interleukin-1 receptor antagonist (IL-1RA) is a potential stroke treatment candidate. Intranasal delivery is a novel method thereby a therapeutic protein can be penetrated into the brain parenchyma by bypassing the blood-brain barrier. Thus, this study tested whether intranasal IL-1RA can provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Hoon, Kam, Eun Hee, Kim, Jeong Min, Kim, So Yeon, Kim, Eun Jeong, Cheon, So Yeong, Koo, Bon-Nyeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340539/
https://www.ncbi.nlm.nih.gov/pubmed/27530114
http://dx.doi.org/10.4062/biomolther.2016.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340539/
https://www.ncbi.nlm.nih.gov/pubmed/27530114
http://dx.doi.org/10.4062/biomolther.2016.050

Ejemplares similares